| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MEDIVATION INC | 2,279,519 | 175,705,000 | 78.30% | ||
| 2 | AMPIO PHARMACEUTICALS INC | 2,964,401 | 24,753,000 | 11.03% | ||
| 3 | ALCOBRA LTD | 687,000 | 11,892,000 | 5.30% | ||
| 4 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 3,076,000 | 1.37% | ||
| 5 | SYNTHETIC BIOLOGICS INC | 1,360,000 | 2,394,000 | 1.07% | ||
| 6 | NEWLINK GENETICS CORP | 77,437 | 2,056,000 | 0.92% | ||
| 7 | NORTHWEST BIOTHERAPEUTICS INC | 200,300 | 1,344,000 | 0.60% | ||
| 8 | INOVIO PHARMACEUTICALS INC | 102,088 | 1,109,000 | 0.49% | ||
| 9 | Advaxis Inc. | 225,000 | 709,000 | 0.32% | ||
| 10 | Galmed Pharmaceuticals Ltd | 65,000 | 633,000 | 0.28% | ||
| 11 | Nephrogenex Inc | 50,000 | 301,000 | 0.13% | ||
| 12 | PROVECTUS BIOPHARMACEUTICALS I | 200,000 | 172,000 | 0.08% | ||
| 13 | Advaxis Inc. | 112,500 | 115,000 | 0.05% | ||
| 14 | CELSUS THERAPEUTICS PLC | 14,155 | 78,000 | 0.03% | ||
| 15 | Echo Therapeutics Inc | 27,430 | 62,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-14-050192, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
